DocGo Inc. (DCGO)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 94 | 319 | 441 | 624 | 617 | 322 | 295 | 307 |
| Operating profit | $m | -89 | -111 | ||||||
| Net profit | $m | -14 | 24 | 35 | 7 | 20 | -182 | -192 | -49 |
| EPS reported | $ | -1.84 | -1.96 | ||||||
| Operating cashflow per share | $ | 0.35 | -0.23 | ||||||
| Capex per share | $ | 0.08 | 0.04 | ||||||
| FCF per share | $ | 0.27 | -0.27 | ||||||
| Free cash flow | $m | 27 | -27 | ||||||
| Net debt | $m | -51 | -25,698,803 | ||||||
| Book value equity | $m | 144 | 119 | ||||||
| Book value per share | $ | 1.45 | 1.20 | ||||||
| Number of shares | m | 99.07 | 98.8 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.60 | 0.73 | ||||||
| P/S LTM | x | 0.27 | 0.30 | ||||||
| P/FCF LTM | x | 3.22 | -3.20 | ||||||
| EV/EBITDA LTM | x | -0.38 | -0.41 | ||||||
| EV/Sales LTM | x | 0.20 | 0.14 | ||||||
| Earnings Yield LTM | % | -2.10% | -4.84% | ||||||
| FCF Yield | % | +31.07% | -31.21% | ||||||
| Quality | |||||||||
| ROE | % | -126.66% | -115.58% | ||||||
| ROIC | % | -55.78% | -89.44% | ||||||
| Operating margin | % | -27.67% | -37.68% | ||||||
| Gross margin | % | +30.65% | +30.12% | ||||||
| FCF/Sales | % | +8.39% | -9.21% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -47.74% | -52.20% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | -58.11% | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.93 | -1.05 | ||||||
| Net Debt/EBITDA | x | 0.13 | -0.00 | ||||||
| EBIT/Net interest | x | -87.92 | -325.21 | ||||||
| Net debt/market cap | % | +0.27% | +24.74% | ||||||
| Net debt/Equity | x | -0.35 | -215,857.37 | ||||||
| Gross debt/equity | x | 0.20 | 0.22 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free